Mocetinostat

Mocetinostat

CAT N°: 18287
Price:

66.00 56.10

Mocetinostat is an orally available inhibitor of histone deacetylases (HDACs) that selectively targets HDAC1 and 2 (IC50s = 0.15 and 0.29 µM, respectively), less potently inhibits HDAC3 and 11 (IC50s = 1.66 and 0.59 µM, respectively) and has negligible actions against HDAC4-8.{29774,29775} It induces hyperacetylation of histones, causes cell cycle blockade, and induces apoptosis in cancer cells in vitro.{29774,29773} Mocetinostat also has antitumor activity in vivo, blocking the growth of human tumor xenografts in mice.{29774} It also significantly reduces cardiac fibrosis following ischemic heart failure in mice.{29776}

We also advise you